{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:47:45Z","timestamp":1791384465498,"version":"4.3.3"},"reference-count":31,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T00:00:00Z","timestamp":1504828800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurogastroenterology Motil"],"published-print":{"date-parts":[[2018,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Studies suggest that Ineffective Esophageal Motility (<jats:styled-content style=\"fixed-case\">IEM<\/jats:styled-content>) is the manometric correlate of Functional Dysphagia (<jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content>). Currently, there is no accepted therapy for either condition. Buspirone is a serotonin modulating medication and has been shown to augment esophageal peristaltic amplitude in healthy volunteers. We aimed to determine if buspirone improves manometric parameters and symptoms in patients with overlapping <jats:styled-content style=\"fixed-case\">IEM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We performed a prospective, double\u2010blind, placebo\u2010controlled, crossover\u2010style trial of 10 patients with <jats:styled-content style=\"fixed-case\">IEM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content>. The study consisted of two 2\u2010week treatment arms with a 2\u2010week washout period. Outcomes measured at baseline, end of week 2, and week 6 include high resolution esophageal manometry (<jats:styled-content style=\"fixed-case\">HREM<\/jats:styled-content>), the Mayo Dysphagia Questionnaire\u201014 (<jats:styled-content style=\"fixed-case\">MDQ<\/jats:styled-content>\u201014), and the <jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HRQL<\/jats:styled-content>.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age of our 10 patients was 53\u00a0\u00b1\u00a09\u00a0years and 70% were female. After treatment with buspirone, 30% of patients had normalization of <jats:styled-content style=\"fixed-case\">IEM<\/jats:styled-content> on manometry; however, there was 30% normalization in the placebo group as well. Comparing buspirone to placebo, there was no statistically significant difference in the <jats:styled-content style=\"fixed-case\">HREM<\/jats:styled-content> parameters measured. There was also no statistically significant difference in symptom outcomes for buspirone compared to placebo. Of note, patients had a statistically significant decrease in the total <jats:styled-content style=\"fixed-case\">GERD<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">HRQL<\/jats:styled-content> total score when treated with placebo compared to baseline levels.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Despite previous data demonstrating improved esophageal motility in healthy volunteers, our study shows no difference in terms of <jats:styled-content style=\"fixed-case\">HREM<\/jats:styled-content> parameters or symptom scores in <jats:styled-content style=\"fixed-case\">IEM<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">FD<\/jats:styled-content> patients treated with buspirone compared to placebo. Further research is necessary to identify novel agents for this condition.<\/jats:p><\/jats:sec>","DOI":"10.1111\/nmo.13213","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T11:19:57Z","timestamp":1504869597000},"source":"Crossref","is-referenced-by-count":34,"title":["A randomized double\u2010blind placebo\u2010controlled crossover\u2010style trial of buspirone in functional dysphagia and ineffective esophageal motility"],"prefix":"10.1111","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9638-6846","authenticated-orcid":false,"given":"Nitin","family":"Aggarwal","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology Cleveland Clinic  Cleveland OH 44195 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthi Nagavenkata","family":"Thota","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Cleveland Clinic  Cleveland OH 44195 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[{"name":"Department of Biostatistics Cleveland Clinic  Cleveland OH 44195 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Gabbard","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology Cleveland Clinic  Cleveland OH 44195 USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,9,8]]},"reference":[{"key":"e_1_2_10_2_1","first-page":"1459","article-title":"Functional esophageal disorders","volume":"130","author":"Aziz Q","year":"2016","journal-title":"Gastroenterology"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01303162"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2004.30035.x"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12477"},{"issue":"100","key":"e_1_2_10_6_1","first-page":"63","article-title":"Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry","volume":"34","author":"Luciano L","year":"2016","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.03.039"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12813"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/dote\/dow038"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.08.034"},{"key":"e_1_2_10_11_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11894-015-0472-y","article-title":"Ineffective esophageal motility (IEM): the old\u2010new frontier in esophagology","volume":"18","author":"Abdel Jalil AA","year":"2016","journal-title":"Curr Gastroenterol Rep"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.384"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01928.x"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225630.29910.f4"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640615585688"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.mcg.0000225542.03880.68"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1177\/000348941312200801"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318167b89d"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2012.04.032"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2011.01275.x"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1177\/2050640614560453"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2007.00658.x"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-2050.2007.00670.x"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2012.06.036"},{"issue":"3","key":"e_1_2_10_25_1","first-page":"2","article-title":"Oesophageal involvement in scleroderma","volume":"27","author":"Suto G","year":"2009","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.22940"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-003-0812-4"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2007.06.010"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90373-9"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2004.00581.x"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a116483"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.3928\/02793695-20151022-01"}],"container-title":["Neurogastroenterology &amp; Motility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fnmo.13213","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/nmo.13213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,28]],"date-time":"2023-09-28T08:06:33Z","timestamp":1695888393000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/nmo.13213"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,8]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["10.1111\/nmo.13213"],"URL":"https:\/\/doi.org\/10.1111\/nmo.13213","archive":["Portico"],"relation":{},"ISSN":["1350-1925","1365-2982"],"issn-type":[{"value":"1350-1925","type":"print"},{"value":"1365-2982","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,8]]},"article-number":"e13213"}}